Neuropsicofarmacología - GIC 21/128
![Foto de Neuropsicofarmacología - GIC 21/128](/img/grupo.png)
![Foto de Hospital Clinic Barcelona](/img/noimage_org.png)
Hospital Clinic Barcelona
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Clinic Barcelona (63)
2024
-
Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis
Therapeutic Advances in Psychopharmacology, Vol. 14
-
Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study
Spanish Journal of Psychiatry and Mental Health
-
OMERACT systemic lupus erythematosus domain survey
Seminars in Arthritis and Rheumatism, Vol. 68
-
Sex differences in neural projections of fear memory processing in mice and humans
Science Advances, Vol. 10, Núm. 28
-
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)
Seminars in Arthritis and Rheumatism, Vol. 65
2023
-
Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository
Arthritis and Rheumatology, Vol. 75, Núm. 8, pp. 1407-1414
-
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study
Laboratory investigation; a journal of technical methods and pathology, Vol. 103, Núm. 6, pp. 100147
-
Fluctuation of Anti–Domain 1 and Anti–β2-Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies
Arthritis and Rheumatology, Vol. 75, Núm. 6, pp. 984-995
-
Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients
Medicina (Kaunas, Lithuania), Vol. 59, Núm. 8
2022
-
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers
International Journal of Neuropsychopharmacology, Vol. 25, Núm. 6, pp. 468-478
-
NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches
International Journal of Molecular Sciences, Vol. 23, Núm. 13
-
Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index
Arthritis Care and Research, Vol. 74, Núm. 4, pp. 638-647
-
Saving the kidneys in the lupus patient: Beyond immunosuppression, the need to collaborate across multiple disciplines
European Journal of Internal Medicine, Vol. 99, pp. 19-21
2021
-
Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications
Arthritis Care and Research, Vol. 73, Núm. 12, pp. 1789-1795
2020
-
Comparative study between two european inception cohorts of patients with early systemic lupus erythematosus
Clinical and Experimental Rheumatology, Vol. 38, Núm. 5, pp. 925-932
-
Construction of a frailty index as a novel health measure in systemic lupus erythematosus
Journal of Rheumatology, Vol. 47, Núm. 1, pp. 72-81
-
Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach
Arthritis Care and Research, Vol. 72, Núm. 12, pp. 1800-1808
-
Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis
Psychological Medicine, Vol. 50, Núm. 16, pp. 2702-2710
-
Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study
Arthritis and Rheumatology, Vol. 72, Núm. 1, pp. 67-77
-
Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus
Journal of Autoimmunity, Vol. 106